Rowad Engineering signs contract with EIPICO worth EGP 418m
The company added that the total project value amounts to EGP 418m…
EIPICO obtains EDA approval to produce anti-COVID drug before mid-January 2022
EIPICO explained that manufacturing will commence under the supervision of the EDA,…
EIPICO targets 2023 start of Biosimilar Project with EGP 400-600m revenues in 1st year
Local market size for oncology and hormone-based products is estimated at EGP1.5bn,…
EIPICO, Reliance Life Science sign agreement to produce biologic drugs
EIPICO produces 18% of antibiotics available in Egyptian market
Medical Union Pharmaceuticals targets 16% sales growth to EGP 2.9bn in 2021
Company plans to inaugurate three production lines in Q1 of 2021
EIPICO eyes EGP 800m investments over 3 years, excluding biosimilar project
A source has revealed that the Egyptian pharmaceutical company, EIPICO, plans to…
EIPICO to export 100,000 Remdesivir vials to 11 countries
The countries that will receive the Egyptian manufactured vaccine are Russia, Ukraine,…
EIPICO reports 17% y-o-y revenues decline to EGP 1.46bn in H1 2020
Pharmaceutical company underperformed on market, reporting aggressive 31% decline in retail sales
EIPICO begins production of COVID-19 drug approved by Russia, China
The production of the drug comes after EIPICO received approval from the…
EIPICO reports lower production, EGP 93m losses due to COVID-19
Company’s operations suffered from traffic disruption, interruption of shipping and export operations